期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

集体署名论文在美国生物医学期刊和数据库中的标引 被引量：1

原文传递
导出
摘要 集体署名论文在生物医学期刊和数据库中逐年增多,但引文原则、方法比较混乱,造成文献检索困难。本文介绍的引文原则和方法是美国 Council of Science Editors(CSE)2006年制订的,对我国的期刊及数据库标引集体署名论文也有参照作用。
作者 钱寿初 董燕萍 雷水英 王攀智
机构地区 <中华医学杂志(英文版)>编辑部 <国际肝胆胰疾病杂志>(英文)编辑部
出处 《中国科技期刊研究》 CSSCI 北大核心 2007年第5期912-914,共3页 Chinese Journal of Scientific and Technical Periodicals
关键词 集体署名 引文标引 杂志 数据库
分类号 G239.712 [文化科学]
  • 相关文献

参考文献9

  • 1No authors listed.Errors in citation statistics.Nature,2002,415:101.
  • 2Cherfas J.With missing citations reported:nature genome paper jumps.SciWatch,2002,13:8.
  • 3Flanagin A,Fontanarosa PB,DeAngelis CD.Authorship for research groups.JAMA,2002,288:3166-3168.
  • 4Davidoff F for the CSE Task Force on Authorship.Who's the Author?Problems with Biomedical Authorship,and Some Possible Solutions.Science Editor,2000,23:111 -119.
  • 5Dickersin K,Scherer R,Suci ES,Gil-Montero M.Problems with indexing and citation of articles with group authorship.JAMA,2002,287:2772-2774.
  • 6Garcia MJ,Lessick J,Hoffmann MH; CATSCAN Study Investigators.Accuracy of 16-row multidetector computed tomography for the assessment of coronary artery stenosis.JAMA,2006,296:403 -411.
  • 7中国心脏调查组,胡大一,潘长玉.中国住院冠心病患者糖代谢异常研究——中国心脏调查[J].中华内分泌代谢杂志,2006,22(1):7-10. 被引量：471
  • 8姜红,柯元南,Lodoz临床协作组.比索洛尔／氢氯噻嗪复方片治疗中国轻中度原发性高血压的临床疗效和安全性研究[J].中华心血管病杂志,2006,34(7):605-608. 被引量：34
  • 9CSE Editorial Policy.CSE Recommendations for Group-Author Articles in Scientific Journals and Bibliographic Databases.Science Editor,2006,29:75-77.

二级参考文献18

  • 1李素青,田玉华,朱敏,杨超元.中老年糖尿病流行病学调查方法探讨[J].实用老年医学,1996,10(4):175-176. 被引量：13
  • 2European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens, 2003,21:1011-1053.
  • 3Chobanian AV, Bakris GL, Black HR ,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA, 2003,289 : 2560 -2572.
  • 4Fenichel RR, Lipicky RJ. Combination products as first-line pharmacotherapy. Arch Intern Med, 1994,154 : 1429-1430.
  • 5Meredith PA. How to evaluate the duration of blood pressure control :the trough: peak ratio and 24-hour monitoring. J Cardiovasc Pharmacol,1998,31 (Suppl 2) :S17-21.
  • 6Rizzoni D, Parati G, Omboni S, et al. Smoothness index but not T/P ratio estimates balanced 24 - hour blood pressure control and predicts regression of organ damage by antihypertensive treatment. J Hypertens, 1997,15 :S7-11.
  • 7King H,Aubert RE,Herman WH.Global burden of diabetes 1995-2025.Prevalence,numerical estimates and projections.Diabetes Care,1998,21:1414-1431.
  • 8Bartnik M,Malmberg K,Hamsten A,et al.Abnormal glucose tolerance-a common risk factor in patients with acute myocardial infarction in comparison with population-based controls.J Int Med,2004,256:288-297.
  • 9Coutinho M,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4years.Diabetes Care,1999,22:233-240.
  • 10The DECODE study group on behalf of the European Diabetes Epidemiology Group.Glucose tolerance and cardiovascular mortality.Arch Int Med,2001,161:397-404.

共引文献503

同被引文献15

引证文献1

中国科技期刊研究
2007年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部